News

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
If your physician prescribes a new branded drug, though, you and your insurance company have few options. Patent-protected ...
Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
Coronavirus in California FOX 11 'Razor blade throat': What to know about COVID-19 variant NB.1.8.1 A new COVID-19 variant, NB.1.8.1, is being monitored by the World Health Organization.